Category: Infectious Diseases

Infectious Diseases

FDA Clears Roche Respiratory Panel with Expanded Pathogen Coverage

New cobas eplex RP3 panel detects up to 19 respiratory pathogens, including Bordetella pertussis, with results available in under two hours.

Infectious Diseases

Roche Adds Molecular Testing Capacity in Democratic Republic of Congo Amid Ebola Outbreak

Roche Diagnostics has supplied two molecular testing systems and is training laboratory staff in the Democratic Republic of Congo to expand PCR testing capacity for Bundibugyo virus amid rising Ebola testing demand.

Infectious Diseases

Multicenter Lab Network Evaluates Four Bundibugyo Virus PCR Assays in Two Weeks

A nine-lab network evaluated four Bundibugyo virus PCR assays from two manufacturers in two weeks during the 2026 outbreak, establishing new reference standards, according to a study in The Lancet Infectious Diseases.

Emerging & Zoonotic Diseases

Alveo Technologies and UTMB Partner to Develop Point-of-Care Lassa Fever Diagnostics

Alveo Technologies and UTMB have partnered to develop point-of-care diagnostics for Lassa fever, deploying molecular sensing platforms at clinical sites in Nigeria and Sierra Leone to support real-time pathogen detection.

Flu & Respiratory Infections

Co-Diagnostics Submits FDA Notification for Upper Respiratory Multiplex Test

Co-Diagnostics has submitted a Dual 510(k) and CLIA waiver application to the FDA for its PCR-based flu and RSV test, aiming to enable point-of-care use on the Co-Dx PCR Pro instrument.

Gastrointestinal Infections

Roche Expands Cyclospora Research Testing Portfolio Amid US Outbreak

Roche has launched two new research PCR assays for Cyclospora cayetanensis detection, expanding lab testing options amid a US outbreak and adding flexibility for gastrointestinal pathogen research.

Sexually Transmitted Diseases

HHS Allocates $4 Million for Rapid Syphilis Testing and Treatment

HHS has allocated $4 million to expand rapid syphilis testing in emergency departments and nontraditional settings, aiming to address a 700% rise in congenital syphilis cases over the past decade, according to agency data.